Trajectories of Mini-Mental State Examination Scores over the Lifespan in General Populations: A Systematic Review and Meta-Regression Analysis.

Conclusions: Between the age of 29 and 105 years MMSE scores decline, with the highest decline between age 84 and 105 years.Clinical Implementations: The use of MMSE should be restricted to higher age categories in aging general populations. PMID: 32374211 [PubMed - as supplied by publisher]
Source: Clinical Gerontologist - Category: Geriatrics Tags: Clin Gerontol Source Type: research

Related Links:

CONCLUSION: Frequent engagement in late life cognitive activity may help maintain decision-making among older persons, particularly among those with lower levels of cognitive function. PMID: 32646635 [PubMed - as supplied by publisher]
Source: The American Journal of Geriatric Psychiatry - Category: Psychiatry Tags: Am J Geriatr Psychiatry Source Type: research
Authors: PMID: 32643872 [PubMed - in process]
Source: The Journal of Alzheimers Association - Category: Psychiatry Tags: Alzheimers Dement Source Type: research
CONCLUSIONS: This panel of 6 markers in blood serum may indicate underlying neurodegenerative processes in patients with AD at the MCI stage. The authors assume that a deranged equilibrium of neuroprotective and inflammatory processes is an overall major cause for neurodegeneration and cognitive decline. PMID: 32649324 [PubMed - as supplied by publisher]
Source: Alzheimer Disease and Associated Disorders - Category: Psychiatry Tags: Alzheimer Dis Assoc Disord Source Type: research
With interest, we read the study of Mangino et al (Am J Geriatr Psychiatry 28:4 (2020) 466-477) in which they reviewed 75 cases of euthanasia and assisted suicide (EAS) in persons with dementia in the Netherlands published by the Dutch regional euthanasia review committees (RTE) (2011-2018). This overview indeed offers an unique insight into aspects of current practice, on an individual patient level. However, a number of issues need to be taken into account more explicitly when interpreting this report.
Source: The American Journal of Geriatric Psychiatry - Category: Geriatrics Authors: Tags: Letter to the Editor Source Type: research
We thank Marijnissen et al.1 for their thoughtful comments and an opportunity to provide additional context to our paper.2 Their letter, however, includes some errors and potentially misleading statements. They begin by asserting that we mischaracterized the EAS review process. They quote us as describing the review as “afterwards reviewing a self-report subjective report of the physician.”1 What we actually wrote, which remains accurate, was: “…the retrospective oversight system relies on self-reports by physicians involved in the EAS process.”2
Source: The American Journal of Geriatric Psychiatry - Category: Geriatrics Authors: Tags: Letter to the Editor Source Type: research
The introduction of psychotropic drugs in the 1950s revolutionized the understanding and treatment of severe psychiatric disorders, undoubtedly alleviating the symptom burden and improving daily functioning for persons with severe affective and psychotic disorders1. Today, these drugs are often used off-label, thus the use of psychotropic drugs for managing behavioral and psychological symptoms of dementia (BPSD) warrants special attention2-5. BPSD such as delusions, hallucinations, agitation, anxiety, and aberrant motor behavior are associated with poorer physical and cognitive functioning as symptoms persist and reoccur ...
Source: The American Journal of Geriatric Psychiatry - Category: Geriatrics Authors: Tags: Regular Research Article Source Type: research
Authors: Stepien K, Furczynska P, Zalewska M, Nowak K, Wlodarczyk A, Owsianka I, Skorek P, Zalewski J, Nessler J Abstract BACKGROUND: Recently heart failure (HF) has been found to be a new dementia risk factor, nevertheless their relations in patients following HF decompensation remain unknown. We sought to investigate whether a screening diagnosis for dementia (SDD) in this high-risk population may predict unfavorable long-term clinical outcomes. METHODS: 142 patients following HF decompensation requiring hospitalization were enrolled. Within a median time of 55 months all patients were screened for dementia w...
Source: Minerva Cardioangiologica - Category: Cardiology Tags: Minerva Cardioangiol Source Type: research
Conditions:   Cognitive Impairment;   Stroke;   Dementia Intervention:   Behavioral: Self-monitoring and personalized feedback on smartphone app Sponsor:   Second Affiliated Hospital, School of Medicine, Zhejiang University Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
Conditions:   Alzheimer Disease;   Dementia;   Mild Cognitive Impairment Intervention:   Sponsor:   UsAgainstAlzheimer's Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
Older adults with higher levels of a specific protein in their blood have better cognitive function and might be at lower risk for dementia than those with lower levels, according to a study published on Friday.
Source: Health News - UPI.com - Category: Consumer Health News Source Type: news
More News: Brain | Dementia | Geriatrics | Men | Neurology